Görög S. .2015 .Identification in drug quality control and drug research. TrAC Trends in Analytical Chemistry, 69 : 114-122.
Gillis J. C.,Markham A. .1997 .Irbesartan: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension. Drugs, 54 : 885-902.
Carey R. A.,Beg M. M.,McNally C. F.,Tannenbaum P. .1984 .Triamterene and renal lithiasis: a review. Clinical Therapeutics, 6(3) : 302-309.
Patil A.,Bhide S.,Bookwala M.,Soneta B.,Shankar V.,Almotairy A.,Narasimha Murthy S. .2018 .Stability of organoleptic agents in pharmaceuticals and cosmetics. AAPS pharmscitech, 19 : 36-47.
Dorofeev V. L.,Arzamastsev A. P.,Veselova O. M. .2004 .Melting Point Determination for the Analysis of Drugs of the Fluoroquinolone Group. Pharmaceutical Chemistry Journal, 38(6) : .
Saha R. N.,Sajeev C.,Jadhav P. R.,Patil S. P.,Srinivasan N. .2002 .Determination of celecoxib in pharmaceutical formulations using UV spectrophotometry and liquid chromatography. Journal of pharmaceutical and biomedical analysis, 28(3-4) : 741-751.
Jouyban A.,Fakhree M. A. .2012 .Experimental and computational methods pertaining to drug solubility. Toxicity and drug testing, 1 : .
Singh C.,Rao K.,Yadav N.,Bansal N.,Vashist Y.,Kumari S.,Chugh P. .2023 .A review: drug excipient iincompatiblity by ftir spectroscopy. Current Pharmaceutical Analysis, 19(5) : 371-378.